Cindy Cullen – Automated Bedside Glucose Monitoring for Critical Care

Pivotal Trial to Build on Previous Positive Studies; Aims to Further Demonstrate Paradigm-Shifting Potential of Automated, Bedside Glucose Monitoring System in the ICU — The OptiScanner [...]

33rd Annual ISICEM Conference Symposium Features Breakthrough Clinical Results Supporting OptiScanner™ from OptiScan Biomedical

Industry Thought-Leaders Highlight Paradigm-Shifting Potential of Automated, Bedside Glucose Monitoring System for Critically Ill Patients BRUSSELS, Belgium, March 21, 2013 – OptiScan [...]

OptiScan Biomedical Presents Study Results Demonstrating OptiScanner’s Excellent Glucose Monitoring Accuracy in Critically Ill ICU Patients

All Measurement Readings Demonstrate Sufficient Accuracy to Guide Clinical Treatment Decisions; Results Achieved in Most Severely Ill Patients — BRUSSELS, March 21, 2012 – OptiScan [...]

OptiScan Biomedical Enrolls First Patient in Pivotal U.S. Clinical Study of OptiScanner® 5000

33rd Annual ISICEM Conference Symposium Features Breakthrough Clinical Results Supporting OptiScanner™ from OptiScan Biomedical

OptiScan Biomedical Presents Study Results Demonstrating OptiScanner’s Excellent Glucose Monitoring Accuracy in Critically Ill ICU Patients